Clinical trial

Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.

NCT02309723

Study summary

ClinicalTrials.gov

Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Beta amyloid imaging Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhaseNA

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Mild Cognitive Impairmentunresolved

Interventions

Beta amyloid imagingDEVICE

Sponsors & collaborators

Tufts Medical Centerlead sponsor

GE Healthcarecollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02309723 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.